Dr. drh. Pamungkas Bagus Satriyo, Ph.D. merupakan lulusan International Ph.D. Program in Medicine, Faculty of Medicine, Taipei Medical University pada tahun 2020. Beliau mendapatkan runner up presentasi oral pada Taipei International Breast Cancer Symposium, Taiwan tahun 2018. Pada tahun 2021, beliau mengikuti Program Postdoctoral di Universitas Gadjah Mada dengan penelitian targeted therapy pada sel kanker serviks dan cancer stem cell ( in vitro). Saat ini, beliau fokus penelitian pada bidang targeted therapy kanker secara in silico dan in vitro. Selain itu beliau juga sedang mengembangkan model hewan Triple Negative Breast Cancer Syngeneic Mice Model sebagai sarana uji aktivitas anti kanker kandidat obat. Beberapa hibah yang beliau dapatkan Riset Kolaborasi Indonesia RKI (2022), Rispro LPDP (2022), dan PTUPT (2021).
EMAIL:
pamungkas.bagus.s@mail.ugm.ac.id
PENDIDIKAN:
- S1: Kedokteran Hewan, Universitas Gadjah Mada (2013)
- S2: Ilmu Kedokteran Dasar & Biomedis, Universitas Gadjah Mada (2016)
- S3: Program Doktor (double degree) Universitas Gadjah Mada & Taipe Medical University (2020)
MINAT PENELITIAN:
Cancer targeted therapy, cancer drug discovery, cancer bioinformatic
PENELITIAN:
- Targeted therapy pada Luminal B breast cancer dengan senyawa turunan pirazoline (2022-2023).
- Pengembangan secretome untuk terapi pada COVID19 (2022).
- RKI : Pengembangan senyawa pirazoline sebagai targeted therapy pada breast cancer (2022).
- Penelitian postdotoral UGM: Pengembangan senyawa pirazoline sebagai targeted therapy pada cervical cancer (2021).
- Rispro : Sekretom stem cell untuk penyakit CKD (2022-sekarang).
- Cadherin 11 Inhibition Downregulates β-catenin, Deactivates the Canonical WNT Signalling Pathway and Suppresses the Cancer Stem Cell-Like Phenotype of Triple Negative Breast Cancer (2016-2019).
- Bruton Tyrosine Kinase Regulate the Cancer Stem Cell-like and EGFR Inhibitor Resistant Phenotype in Non-Small Lung Cancer Cell (2016-2019).
- 4-Acetylantroquinonol B Suppresses Cell Proliferation and Induces Apoptosis Through CDK2/CDK4-DDR Axis Inhibition in Triple Negative Breast Cancer (2017-2020).
- Hydroxy-antrocin: a novel small compound suppresses cell proliferation and cancer stemness of hepatocellular carcinoma via ERK/AKT signaling inhibition (2019-2020).
- Synergistic effect of ovatodioloide and antrocin inhibit cell proliferation and cancer stemness of hepatocelular carcinoma via MAPK/PI3K/Wnt signaling pathways (2019-2020).
- 4-Acetylantroquinonol B treatment effect of pancreatic cancer 9(2019-2020).
PUBLIKASI:
Google Scholar | Scopus | SINTA | PubMed
| Publikasi | Tahun | Jurnal | Penulis |
| A Potent EGFR Inhibitor, N-Phenyl Pyrazoline Derivative Suppresses Aggressiveness and Cancer Stem Cell-Like Phenotype of Cervical Cancer Cells | 2022 | Drug Design , Development and Therapy, Dove Press. Vo: 16 | Mustofa, Pamungkas Bagus Satriyo, Artania Adnin Tri Suma, Stephanus Satria Wira Waskitha, Tutik Dwi Wahyuningsih, Eti Nurwening Sholikhah1 |
| Cadherin 11 Inhibition Downregulates β-catenin, Deactivates the Canonical WNT Signalling Pathway and Suppresses the Cancer Stem Cell-Like Phenotype of Triple Negative Breast Cancer | 2019 | Journal of Clinical Medicine, MDPI. Vol: 8(2)/148 | Pamungkas Bagus Satriyo, Oluwaseun Adebayo Bamodu, Jia-Hong Chen, Teguh Aryandono, Sofia Mubarika Haryana, Chi-Tai Yeh, Tsu-Yi Chao |
| Potential Movement of CDK 4/6 Inhibitor from Cell Cycle Arrest to Immune Activation in Breast Cancer | 2019 | Cancer Therapy & Oncology International Journal, Juniper. Vol: 13(1) | Pamungkas Bagus Satriyo |
| Dual therapeutic strategy targeting tumor cells and tumor microenvironment in triple-negative breast cancer | 2020 | Journal of Research Cancer and Practice. Vol: 7(4) | Pamungkas Bagus Satriyo, Chi- Tai Yeh, Jia- Hong Chen, Teguh Aryandono4, Sofia Mubarika Haryana, Tsu- Yi Chao |
| Bruton’s tyrosine kinase (BTK) mediates resistance to EGFR inhibition in non-small-cell lung carcinoma | 2021 | Oncogenesis. Vol. 10 (7), 1-13 | Chi-Tai Yeh, Tzu-Tao Chen, Pamungkas Bagus Satriyo, Chun-Hua Wang, Alexander T. H. Wu, Tsu-Yi Chao, Kang-Yun Lee, Michael Hsiao, Liang-Shun Wang & Kuang-Tai Kuo |
| 4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells | 2021 | Toxicology and Applied Pharmacology. Vol: 422, 115493 | Pamungkas Bagus Satriyo, Chih Ming Su, Jiann Ruey Ong, Wen-Chien Huang, Iat-Hang Fong, Chih-Cheng Lin, Teguh Aryandono, Sofia Mubarika Haryana, Li Deng, Chun-Chih Huang, Yew-Min Tzeng, Tsu-Yi Chao, Hui-Wen Liu, Chi-Tai Yeh |
